{"id":"NCT00932646","sponsor":"Boehringer Ingelheim","briefTitle":"Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease","officialTitle":"Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-06","primaryCompletion":"2010-05","completion":null,"firstPosted":"2009-07-03","resultsPosted":"2014-06-27","lastUpdate":"2016-02-05"},"enrollment":100,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"BI 1744 (Olodaterol) Low Dose","otherNames":[]},{"type":"DRUG","name":"BI 1744 (Olodaterol) Medium Dose","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Foradil","otherNames":[]}],"arms":[{"label":"BI1744 (Olodaterol)","type":"EXPERIMENTAL"},{"label":"BI 1744 (Olodaterol)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Foradil","type":"ACTIVE_COMPARATOR"}],"summary":"The study is intended to characterize the lung function profile of BI1744 in COPD patients where patients will perform pulmonary function tests at regular intervals for 24 hours at the end of a 6 week treatment period. Each patient will receive all four treatments.","primaryOutcome":{"measure":"FEV1 Area Under Curve 0-12 h (AUC 0-12h) Response After Six Weeks of Treatment","timeFrame":"1 hour (h) and 10 minutes (min) prior to am dose on the first day of treatment (baseline) and -30 min (zero time), 30 min, 60 min, 2 hour (h) , 3 h, 4 h, 6 h, 8 h, 10 h, 11 h 50 min relative to am dose after six weeks of treatment","effectByArm":[{"arm":"Placebo","deltaMin":-0.022,"sd":0.024},{"arm":"Olo 5 mcg qd","deltaMin":0.15,"sd":0.024},{"arm":"Olo 10 mcg qd","deltaMin":0.152,"sd":0.024},{"arm":"Form 12 mcg Bid","deltaMin":0.136,"sd":0.024}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG003","p":"<0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":15},"locations":{"siteCount":13,"countries":["United States"]},"refs":{"pmids":["25187881"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":94},"commonTop":["Chronic obstructive pulmonary disease","Upper respiratory tract infection"]}}